{"id":101186,"date":"2026-08-10T17:41:45","date_gmt":"2026-08-10T08:41:45","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/8275-20260810-01_wp_financial_summary\/"},"modified":"2026-08-10T17:41:45","modified_gmt":"2026-08-10T08:41:45","slug":"8275-20260810-01_wp_financial_summary","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/","title":{"rendered":"Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated)"},"content":{"rendered":"<p>Revenue 16,865 million yen (YoY +5.4%), operating income 344 million yen (YoY +67.4%), ordinary income 444 million yen (YoY +80.3%), net income attributable to owners of the parent 115 million yen (YoY +79.3%). Full-year dividend is expected to 32 yen. By segment, Corporate Doctor Group revenue 8,659 million yen, segment profit 187 million yen; Business Solution Group revenue 8,205 million yen, segment profit 154 million yen. Total assets at quarter-end 38,159 million yen, net assets 20,796 million yen, equity ratio 48.2%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8275","jir_company_name":"Fobal","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/8275-20260810-01.pdf","jir_short_summary":"Revenue 16,865 million yen (YoY +5.4%), operating income 344 million yen (YoY +67.4%), ordinary income 444 million yen (YoY +80.3%), net income attributable to owners of the parent 115 million yen (YoY +79.3%). Full-year dividend is expected to 32 yen. By segment, Corporate Doctor Group revenue 8,659 million yen, segment profit 187 million yen; Business Solution Group revenue 8,205 million yen, segment profit 154 million yen. Total assets at quarter-end 38,159 million yen, net assets 20,796 million yen, equity ratio 48.2%.","jir_summary":"### Business Performance Overview\nFor the first quarter cumulative period, revenue grew 5.4% year over year to 16,865 million yen as a result of expanding digital and AI-enabled services and steady progress in DX and GX-related initiatives. Operating income rose 67.4% to 344 million yen, ordinary income increased 80.3% to 444 million yen, and net income attributable to owners of the parent grew 79.3% to 115 million yen, marking significant improvement. By segment, Corporate Doctor Group revenue was 8,659 million yen with segment profit of 187 million yen, and Business Solution Group revenue was 8,205 million yen with segment profit of 154 million yen. Although costs associated with new investments increased, overall efficiency and growth strategy were balanced.\n\n### Financial Position and Dividend Outlook\nTotal assets at quarter-end stood at 38,159 million yen, net assets 20,796 million yen, and equity ratio 48.2%. The full-year dividend is expected to be 32 yen. There are no changes to the full-year earnings guidance, and the policy remains to continue growth investments while sustaining shareholder returns.","jir_financial_highlights":"Revenue: 16,865 (YoY +5.4%)\nOperating income: 344 (YoY +67.4%)\nOrdinary income: 444 (YoY +80.3%)\nNet income attributable to owners of the parent: 115 (YoY +79.3%)\nTotal assets: 38,159 (Decrease vs end of previous period)","jir_category":"","jir_hashtags":"#Fobal, #Earnings, #RevenueIncrease, #Segment, #ROEImprovement","jir_key_figures":"Revenue: 16,865 million yen\nOperating income: 344 million yen\nOrdinary income: 444 million yen","jir_meta_title":"\u3010Fobal\u3011Q1 FY2027 Financial Results\uff5cRevenue 16,865 million yen, Operating income 344 million yen","jir_meta_description":"Key points of Fobal's Q1 FY2027 financial results. Revenue up 5.4% YoY, operating income up 67.4%, segment trends and future dividend policy explained.","jir_og_title":"Fobal's Q1 Results: Revenue Growth and Profit Expansion","jir_og_description":"Fobal reports revenue increase and substantial profit growth in Q1 FY2027, with a dividend policy of 32 yen. Segment details included.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57189,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-101186","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated) - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/\",\"name\":\"Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated) - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-08-10T08:41:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated) - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/","url":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/","name":"Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated) - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-08-10T08:41:45+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20260810-01_wp_financial_summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Q1 2027 Financial Results for the Fiscal Year Ending March 2027 (Japan GAAP) (Consolidated)"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"57189","title":"FORVAL CORP","ticker":"8275"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/101186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=101186"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/101186\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=101186"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=101186"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=101186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}